| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59118573f516674ac0927f5ad4c26eeb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-0281
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3679
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3687 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J47-02 |
| filingDate |
2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8a433d6d0ad408c05bc96c4f0471791
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f699efef5bc7b7f957c68c7f97a08bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7a69050a068931251f757973e682c7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c10ff86a8dd4228edc723f9d89bab37b |
| publicationDate |
2020-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10617813-B2 |
| titleOfInvention |
Therapeutic compositions for viral-associated disease states and methods of making and using same |
| abstract |
A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject. |
| priorityDate |
2014-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |